Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| End Stage Liver Disease | 1 | 2018 | 418 | 0.53 | Why? |
| Respiratory Insufficiency | 2 | 2020 | 7301 | 0.36 | Why? |
| Hepatopulmonary Syndrome | 2 | 2018 | 12 | 0.24 | Why? |
| Obesity | 1 | 2020 | 7388 | 0.20 | Why? |
| Hydrothorax | 1 | 2018 | 9 | 0.19 | Why? |
| Respiration, Artificial | 3 | 2020 | 22116 | 0.19 | Why? |
| Personnel, Hospital | 2 | 2020 | 2273 | 0.16 | Why? |
| Chemoprevention | 1 | 2021 | 585 | 0.16 | Why? |
| Liver Failure | 1 | 2018 | 266 | 0.15 | Why? |
| Hydroxychloroquine | 3 | 2021 | 12447 | 0.12 | Why? |
| Liver Transplantation | 2 | 2018 | 2864 | 0.12 | Why? |
| L-Lactate Dehydrogenase | 1 | 2020 | 1995 | 0.12 | Why? |
| Hypertension, Pulmonary | 2 | 2018 | 970 | 0.12 | Why? |
| Ferritins | 1 | 2020 | 2055 | 0.11 | Why? |
| Pulmonary Medicine | 1 | 2017 | 706 | 0.10 | Why? |
| Recovery of Function | 1 | 2020 | 2461 | 0.10 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.09 | Why? |
| Fellowships and Scholarships | 1 | 2017 | 931 | 0.09 | Why? |
| Perioperative Care | 1 | 2018 | 1329 | 0.09 | Why? |
| Outpatients | 1 | 2020 | 3417 | 0.08 | Why? |
| Smoking | 1 | 2020 | 3358 | 0.08 | Why? |
| Airway Management | 1 | 2017 | 1298 | 0.08 | Why? |
| Simulation Training | 1 | 2017 | 957 | 0.08 | Why? |
| Lopinavir | 1 | 2021 | 4308 | 0.08 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.07 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
| Education, Medical | 1 | 2020 | 2461 | 0.07 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.06 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.06 | Why? |
| Intensive Care Units | 2 | 2020 | 29594 | 0.06 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.06 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.06 | Why? |
| Education, Medical, Graduate | 1 | 2017 | 2082 | 0.06 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.06 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.06 | Why? |
| United States | 7 | 2021 | 46150 | 0.06 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.05 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.05 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.05 | Why? |
| Humans | 17 | 2021 | 930598 | 0.05 | Why? |
| Vaccines, Synthetic | 2 | 2021 | 3231 | 0.05 | Why? |
| Network Meta-Analysis | 1 | 2020 | 426 | 0.04 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.04 | Why? |
| Academic Medical Centers | 2 | 2020 | 3088 | 0.04 | Why? |
| Antibodies, Viral | 2 | 2020 | 51949 | 0.04 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.04 | Why? |
| World Health Organization | 2 | 2021 | 4213 | 0.04 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.04 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.04 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.04 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.04 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.04 | Why? |
| Male | 9 | 2021 | 367725 | 0.04 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.04 | Why? |
| Female | 9 | 2021 | 380317 | 0.04 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.03 | Why? |
| Aged | 5 | 2021 | 215776 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Critical Care | 1 | 2017 | 14081 | 0.03 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.03 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 1316 | 0.03 | Why? |
| Vaccination Coverage | 1 | 2021 | 1249 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Adult | 7 | 2021 | 244371 | 0.03 | Why? |
| Nephrology | 1 | 2017 | 546 | 0.03 | Why? |
| Organizational Innovation | 1 | 2020 | 2468 | 0.03 | Why? |
| Uncertainty | 1 | 2021 | 1888 | 0.02 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.02 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Teaching | 1 | 2017 | 1208 | 0.02 | Why? |
| Guideline Adherence | 1 | 2020 | 2309 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Emergency Medicine | 1 | 2017 | 936 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2021 | 3755 | 0.02 | Why? |
| Liver Neoplasms | 1 | 2018 | 1666 | 0.02 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.02 | Why? |
| Immunologic Factors | 1 | 2021 | 4206 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Socioeconomic Factors | 1 | 2020 | 8495 | 0.01 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Cardiology | 1 | 2017 | 2873 | 0.01 | Why? |
| Pediatrics | 1 | 2017 | 2969 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2020 | 10649 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
Qadir's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(88)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(441)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_